Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Oral ulcers are common in SLE patients and often link to other symptoms.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Substance from human umbilical cord blood cells promotes hair growth.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Hair care practices and concerns about maintaining hairstyles can reduce how often African American women exercise.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The humanized AA mouse model is better for testing new alopecia areata treatments.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.